This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Khouli, H. Articles by Homel, P. Search for Related Content PubMed PubMed Citation Articles by Khouli, H. Articles by Homel, P. Social Bookmarking                         What's this?

Outcome of Critically Ill Human Immunodeficiency Virus-Infected Patients in the Era of Highly Active Antiretroviral Therapy

St. Luke’s-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York, hkhouli{at}chpnet.org

Ardavan Afrasiabi, MD

St. Luke’s-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York

Muhamad Shibli, MD

St. Luke’s-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York

Rizan Hajal, MD

St. Luke’s-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York

C. Redington Barrett, MD, FCCP

St. Luke’s-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York

Peter Homel, PhD

Albert Einstein College of Medicine, Bronx, New York

The purpose of this study was to determine the effect of prior use of highly active antiretroviral therapy (HAART) on outcome of human immunodeficiency virus (HIV)- patients admitted to intensive care units (ICUs). This study was a retrospective chart review of 242 HIV-infected patients who required 259 consecutive admissions to a university-affiliated hospital ICU during a 3-year period. Patient demographics, CD4 count, admission diagnosis, prior HAART, Pneumocystis jiroveci prophylaxis, length of stay, and ICU and hospital mortality were determined. Overall hospital mortality was 39%. Comparing patients who had received HAART before an ICU admission to those who had not, we found no difference between ICU or hospital mortality, need of mechanical ventilation, ICU and hospital length of stay, and incidence of P jiroveci. Pulmonary diagnosis was the most frequent ICU admission diagnosis (30%). Logistic regression analysis showed HIV-related illness and mechanical ventilation were significant independent predictors of increased hospital mortality.

Key Words: admissions with HIV-related illness • AIDS • highly active antiretroviral therapy (HAART) • outcome • mechanical ventilation • prophylaxis

Journal of Intensive Care Medicine, Vol. 20, No. 6, 279-285 (2005)
DOI: 10.1177/0885066605281087


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J L Davis, A Morris, R H Kallet, K Powell, A S Chi, M Bensley, J M Luce, and L Huang Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury Thorax, November 1, 2008; 63(11): 988 - 993. [Abstract] [Full Text] [PDF]

				R. E. Davaro and A. Thirumalai Life-Threatening Complications of HIV Infection J Intensive Care Med, March 1, 2007; 22(2): 73 - 81. [Abstract] [PDF]

				M. J. Rosen Intensive Care of Patients With Human Immunodeficiency Virus Infection: Time to Take Another Look J Intensive Care Med, December 1, 2005; 20(6): 312 - 315. [PDF]